As of 2025-12-22, the Fair Value of Bioatla Inc (BCAB) is -2.61 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.75 USD, the upside of Bioatla Inc is -446.13%.
With the market price of 0.75 USD and our fair value calculation, Bioatla Inc (BCAB) is not a good investment. Investing in Bioatla stocks now will result in a potential loss of 446.13%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -35.85 | -95.40 | -106.48 | -123.46 | -69.78 | -86.19 |
| YoY growth | -20.34% | -166.11% | -11.61% | -15.95% | 43.48% | -34.11% |
| Market Cap (mil) | 44.29 |
| P/E | |
| Forward P/E |
| EPS | -0.52 |
| Avg earnings growth rate | -34.11% |
| TTM earnings | -30.66 |